Vaccine News and Research

Latest Vaccine News and Research

Virusend TX-10 detergent rapidly reduces SARS-CoV-2 infectivity

Researchers at Liverpool School of Tropical Medicine have conducted a study showing that a novel disinfectant called Virusend TX-10 is highly effective at inactivating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

29 Nov 2020

SARS-CoV-2 spike protein shows slow but stable evolution, study finds

A new preprint published in November 2020 describes the seven different clades into which the virus has diversified.

27 Nov 2020

Asian countries need support to get equitable access to COVID-19 vaccines

As three pharma majors, Pfizer Inc with partner BioNTech SE, Moderna Inc. and AstraZeneca Plc announced this month the effectiveness of their experimental vaccines in preventing COVID-19, there were no guarantees that developing countries will get their fair share.

27 Nov 2020

COVID-19 studies have neglected to focus on mucosal immunity, researchers argue

Researchers suggest that COVID-19 studies should focus on how mucous membranes in the mouth and nose develop immunity to the SARS-CoV-2 virus.

27 Nov 2020

Salient Bio launches robotics driven COVID-19 mass testing platform

UK diagnostics firm Salient Bio has announced the commercial roll out of its robotics driven COVID-19 mass testing platform.

27 Nov 2020

Lemann Foundation hails "spirit of co-operation' during wide-scale Brazilian clinical trial of Oxford/AstraZeneca vaccine

Denis Mizne, CEO of the Lemann Foundation, today hailed the “spirit of co-operation” during the wide-scale Brazilian clinical trials that helped deliver the Oxford/AstraZeneca COVID-19 vaccine, following the news that it is up to 90% per cent effective after passing phase-3 global trials.

27 Nov 2020

Siemens Healthineers SARS-CoV-2 IgG antibody test demonstrates ability to detect neutralizing antibodies

Siemens Healthineers has announced its SARS-CoV-2 IgG Antibody Test has proven to measure neutralizing antibodies and has achieved CE Mark. The test is an enhanced version of the assay which became available globally this summer.

From Siemens Healthineers 27 Nov 2020

SARS-CoV-2 immunity can sustain for at least eight months, study finds

A new study by researchers at Monash University, Australia, has revealed that people who have been infected with COVID-19 showed sustained protection against reinfection for at least eight months.

26 Nov 2020

Recurrent SARS-CoV-2 mutations do not significantly increase transmissibility, says study

A team of researchers at the Genetics Institute, University College London, tested whether any homoplasies observed in SARS-Cov-2 to date are significantly linked to increased viral transmission.

26 Nov 2020

Specific SARS-CoV-2 genomic variations are associated with higher COVID-19 deaths

A team of scientists from South Korea and the United States has conducted an interesting study to investigate whether mutations in the genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can affect the severity of coronavirus disease 2019 (COVID-19). The study findings reveal that mutations in the viral spike protein and RNA polymerase complex can increase the risk of COVID-19 mortality.

25 Nov 2020

COVID-19 vaccine candidate tested preclinically at UAB poised for Phase 1 clinical study

A COVID-19 vaccine candidate that underwent extensive preclinical testing at the University of Alabama at Birmingham this spring and summer is poised for clinical testing to begin in December.

25 Nov 2020

Genomic analysis provides clues about SARS-CoV-2 ancestry and transmission

Researchers in the UK conducting a genomic analysis of severe acute respiratory virus syndrome coronavirus 2 (SARS-CoV-2) and SARS-like coronaviruses in the bat and pangolin have identified strong host-associated divergences that could provide clues about the ancestry and interspecies transmission of SARS-CoV-2.

25 Nov 2020

Researchers discover close SARS-CoV-2-relative in animal hosts outside China

In a major new discovery that might deepen our understanding of SARS-CoV-2’s animal origins and its genetic evolution, coronaviruses very closely related to SARS-CoV-2 have been discovered in two horseshoe bats outside of China.

25 Nov 2020

Convalescent plasma therapy ineffective in treating severe COVID-19, study finds

A recent study based at a hospital in Buenos Aires, Argentina, found that convalescent plasma therapy for patients with severe COVID-19, and COVID-19-related pneumonia, was largely ineffective.

25 Nov 2020

Study: None of the SARS-CoV-2 mutations appear to increase transmissibility in humans

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

25 Nov 2020

The American Lung Association say to wear masks to stop the spread of COVID-19; Here’s why

Dr. Albert Rizzo speaks to News-Medical about the importance of wearing masks to help control the spread of COVID-19.

25 Nov 2020

BCG vaccination appears to trigger cross-reactive SARS-CoV-2-specific T cell response

Recently, researchers from the Monash University and Monash Medical Centre, Clayton, Victoria, Australia, investigated whether peptide sensitization using BCG can produce cross-reactive T cells specific to SARS-CoV-2. Their study is published on the preprint server, medRxiv.

24 Nov 2020

A review of Traditional Chinese herbal medicine in management of COVID-19

Now researcher have summarized the experiences with the use of traditional Chinese herbal medicines for the management of COVID-19. Their study titled, “Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis,” was published in the January 2021 issue of the journal Phytomedicine.

24 Nov 2020

Protection of upper respiratory tract will require vaccines that mimic natural infection by SARS-CoV-2

Recently, a team of researchers studied the transmission modes of SARS-CoV-2 and the protection against re-infection in ferret models in work published on the preprint server, bioRxiv.

24 Nov 2020

Mild COVID-19 disease may trigger long-term immunity

Researchers in the United States have conducted a study showing that individuals who have recovered from mild coronavirus disease 2019 (COVID-19) developed sustained protective immune memory against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

24 Nov 2020

Vaccine News and Research

Latest Vaccine News and Research

Virusend TX-10 detergent rapidly reduces SARS-CoV-2 infectivity

SARS-CoV-2 spike protein shows slow but stable evolution, study finds

Asian countries need support to get equitable access to COVID-19 vaccines

COVID-19 studies have neglected to focus on mucosal immunity, researchers argue

Salient Bio launches robotics driven COVID-19 mass testing platform

Lemann Foundation hails "spirit of co-operation' during wide-scale Brazilian clinical trial of Oxford/AstraZeneca vaccine

Siemens Healthineers SARS-CoV-2 IgG antibody test demonstrates ability to detect neutralizing antibodies

SARS-CoV-2 immunity can sustain for at least eight months, study finds

Recurrent SARS-CoV-2 mutations do not significantly increase transmissibility, says study

Specific SARS-CoV-2 genomic variations are associated with higher COVID-19 deaths

COVID-19 vaccine candidate tested preclinically at UAB poised for Phase 1 clinical study

Genomic analysis provides clues about SARS-CoV-2 ancestry and transmission

Researchers discover close SARS-CoV-2-relative in animal hosts outside China

Convalescent plasma therapy ineffective in treating severe COVID-19, study finds

Study: None of the SARS-CoV-2 mutations appear to increase transmissibility in humans

The American Lung Association say to wear masks to stop the spread of COVID-19; Here’s why

BCG vaccination appears to trigger cross-reactive SARS-CoV-2-specific T cell response

A review of Traditional Chinese herbal medicine in management of COVID-19

Protection of upper respiratory tract will require vaccines that mimic natural infection by SARS-CoV-2

Mild COVID-19 disease may trigger long-term immunity

eBook: Advancing infectious disease vaccine development eBook

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Vaccine News and Research

Latest Vaccine News and Research

eBook: Advancing infectious disease vaccine development eBook

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Newsletters you may be interested in